CBD with CBDA & CBDG | Full Spectrum CBD | 2022 Best Prices




Our Premium Full Spectrum CBD Oil Tincture with CBDA & CBGA

Are you dealing with anxiety, pain, insomnia, or any other issue? Do you feel like CBD isn’t enough? Our Premium Full-Spectrum CBD with CBDA & CBGA Tincture offers more benefits.

Did you think CBD was enough?

CBD is amazing, but there are more than 100 cannabinoids. THC, CBG, CBDA, CBGA, and CBDV are just a few of the many cannabinoids. Science has demonstrated that each cannabinoid might have its own health effects. Therefore, CBD alone may not be as beneficial as Full-Spectrum CBD.

Enhance your CBD Experience.

A variety of foods is key to healthy living. The combination of different cannabinoids creates an “Entourage Effect,” which means that each cannabinoid increases the effect of the others.

FULL PEER-REVIEWED STUDY HERE: https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00946


Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants


As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection–mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid acids from hemp (Cannabis sativa) were found to be allosteric as well as orthosteric ligands with micromolar affinity for the spike protein. In follow-up virus neutralization assays, cannabigerolic acid and cannabidiolic acid prevented infection of human epithelial cells by a pseudovirus expressing the SARS-CoV-2 spike protein and prevented entry of live SARS-CoV-2 into cells. Importantly, cannabigerolic acid and cannabidiolic acid were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2.


The Full-Spectrum includes CBD, CBG, and THCV for a greater range of health benefits.

CBD Benefits



CBD could have many health benefits:

  • Chronic pain

  • Sleep Disorders

  • Antioxidant Effects

CBD could be an alternative to other painkillers and other drugs that is safer and less psychoactive than traditional opioids.

“CBD does not have any effects that could indicate abuse or dependence.” – World Health Organization Report.

CBD could have many health benefits:
Chronic pain
Sleep Disorders
Antioxidant Effects
CBD could be an alternative to other painkillers and other drugs that is safer and less psychoactive than traditional opioids.

“CBD does not have any effects that could indicate abuse or dependence.” – World Health Organization Report.


CBG Benefits

CBG Benefits


CBG could offer these benefits:

  • Chronic Inflammation

  • IBS/Colitis

  • Acne

  • Memory

CBG might have strong anti-bacterial properties to treat skin conditions.

CBDA Benefits

CBDA Benefits Corona Virus Spike Protein


What are CBDa’s benefits?

  • 1.) Inflammation. Laboratory research performed in cell cultures has found that CBD with CBDA & CBDG has potential anti-inflammatory properties.
  • 2.) Nausea & vomiting. It has been found that certain cannabis juice may benefit those with a queasy stomach. 
  • 3.) Psychosis
  • 4.) Anti-Cancer


CBGA Benefits

CBGA Benefits COVID-19 Spike Proteins

CBGA Benefits COVID-19 Spike Proteins

CBGA is the mother of all cannabinoids. CBGA is produced by cannabis plants through a process known as biosynthesis. CBGA is converted into THCA, CBDA, or CBCA as the cannabis plant matures. Any remaining CBGA from the cannabis plant will be decarboxylated into CBG when it is heated. This unique cannabinoid is responsible for all the medicinal benefits of cannabis. CBGA also has anti-inflammatory, analgesic, and anti-bacterial properties.



PORTLAND, Ore., (KOIN) — A recent research by Oregon State University found that hemp compounds could prevent coronavirus. This could have major implications for the growing CBD market.

OSU study published Jan. 10, 2022. It identified CBDa, and CBGa, as compounds in hemp that can prevent the COVID-19 virus from entering human cells.

Redemperorcbd.com CEO James Baines IV  was not surprised by OSU’s findings. However, he told KOIN6 News that he was excited for more research into the potential benefits of hemp products.

Mr. Baines stated that cannabinoids are not being studied as much as they should. “People have used them since before the dawn of time. However, they have not been studied as there are still legal gray areas depending on where you live.”

Mr. Baines is the CEO of the best hemp-derived CBD manufacturing operation in the country. He believes research such as the OSU study can help to destigmatize cannabinoid usage and encourage further research and legalization.

Mr. Baines stated that this will push some institutions to support cannabinoid-related research now that people understand the many benefits of cannabis. COVID appears to be a condition that affects older people, and some older people have a negative stigma about cannabis.

He said, “Over time, we’ve seen this stigma disappear, especially in states such as Oregon, where recreational marijuana has become a national issue.” This will make it easier for some older people to understand that the plant has parts that can get you high, as well as medicinal benefits.

Redemperorcbd.com stocks CBDa, CBGa, and other CBD compounds as per the OSU study. However, FDA guidelines prohibit Mr. Baines company from using the research to promote its products. But it doesn’t stop us from linking to other articles. It’s called FREEDOM OF SPEECH you see and if you don’t believe BING My lawyer Aaron Pelley

Mr. Baines said that the FDA prohibits us from using this research to our advantage right now. This is perfectly fine. Mr. Baines said, “We can sell the product, but can’t educate consumers on the research being done.”

Mr. Baines said that despite the limitations, Mr. Baines assured KOIN 6 News that the OSU study and similar studies will continue to encourage the nation’s acceptance of the cannabinoids in the plant. This could have a positive impact on the health of large numbers of the country’s population.

Terwilliger stated that the study’s findings regarding the potential to lower the COVID-19 rate are clear and important for citizens around the US, as well as for CBD and the cannabinoid industries. What’s more, people are beginning to look at CBD and other components of the plant to see the benefits they can offer citizens in the US.






Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

COVID-19 has spread rapidly, highlighting the need to find new treatments. We report here that CBD, a compound found in cannabis plants, inhibits SARS/CoV-2 infection. CBD and its metabolite 7-OH-CBD but not congeneric cannabis cannabinoids potently inhibit SARS-CoV-2 replication within lung epithelial cell lines. CBD works after cellular infection, blocking viral gene expression and reversing many of the effects of SARS-2 on host gene transcript. CBD increases interferon production and regulates its antiviral signaling pathway. The SARS-CoV-2 incidence in a cohort of patients who had previously taken CBD was significantly lower than that of matched pairs or the general public. This study highlighted CBD and its active metabolite 7-OH-CBD as possible therapeutic treatments and preventative agents for SARS-CoV-2 in the early stages.

See: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987002/

UW study shows CBD may help protect cells against COVID-19

“When I got my first data, I was like ‘oh my god’,” added Maria Fernandes, a UW post-doctorate fellow who performed the cell studies. “We were so excited to see the immune system was actually activated by CBD and making the cells protect themselves from infecting all the healthy ones.”












The Food and Drug Administration has not evaluated representations regarding the safety and efficacy of CBD-based products from Redemperorcbd.com . FDA does not evaluate supplements, but foods and drugs. These products are not intended for the diagnosis, prevention, treatment, or cure of any disease. Click here (https://www.ncbi.nlm.nih.gov/pubmed/22625422) and here (https://www.ncbi.nlm.nih.gov/pubmed/18728714) to find evidence of a test, analysis, research, or study describing the benefits, performance or efficacy of CBD Oil based on the expertise of relevant professionals.

These statements have not been evaluated or approved by the FDA. They are not intended for diagnosis, treatment, cure, or prevention of any disease. Before you start a new dietary supplement program, make sure to consult your doctor.

These products contain Cannabidiol, which is a natural component of the industrial hemp plant. It was grown in the United States of America. KC Hemp Co. will not distribute or sell products that violate the United States Controlled Substances Act.

product image
Author Rating
Aggregate Rating
5 based on 4 votes
Brand Name
Redemperor CBD
Product Name
Full Spectrum CBD
USD 49.99
Product Availability
Available in Stock

Additional information


500 MG, 1000 MG, 1500 MG, 3000 MG


There are no reviews yet.

Be the first to review “CBD with CBDA & CBDG | Full Spectrum CBD | 2022 Best Prices”

Your email address will not be published. Required fields are marked *

Post comment